Home
/
Conditions
/ Gastroparesis
Gut and Autonomic Health
Schedule a Consultation
Gastroparesis
Gastroparesis is delayed gastric emptying without mechanical obstruction, producing nausea, early satiety, bloating, and vomiting. It is most commonly caused by vagal nerve dysfunction from diabetes, post-surgical damage, or autonomic neuropathy. Conventional treatment manages symptoms with prokinetics and dietary modification. Functional medicine identifies the specific mechanism impairing gastric motility: vagal dysfunction, autonomic neuropathy, blood sugar instability, thyroid dysfunction, SIBO, or medication effects, and treats the driver of the dysmotility rather than just the symptoms.
Gut and AutonomicGastric MotilityMechanism Identification
Vagalvagus nerve dysfunction is the most common mechanism impairing gastric motility
Multi-Causediabetes, autonomic neuropathy, hypothyroidism, SIBO, and medications all cause gastroparesis
Treatablewhen the specific mechanism driving the delayed emptying is identified and corrected
← Back to Conditions
Condition: Gastroparesis | Category: Gut and Autonomic Health | Reviewed by: Brian Lamkin, DO
What Is Gastroparesis?
Gastroparesis is a condition of delayed gastric emptying in the absence of mechanical obstruction. The stomach cannot empty its contents into the duodenum at a normal rate because the smooth muscle contractions that propel food forward are impaired. This produces nausea, vomiting, early satiety (feeling full after a few bites), bloating, upper abdominal pain, and poor nutritional absorption. In severe cases, patients lose significant weight and become malnourished.
Gastric motility is controlled primarily by the vagus nerve (parasympathetic innervation) working in coordination with the interstitial cells of Cajal (pacemaker cells that generate the electrical rhythm of gastric contractions) and the enteric nervous system. Damage or dysfunction at any of these levels produces delayed emptying. Diabetic autonomic neuropathy is the most commonly identified cause, but up to 50 percent of cases are classified as idiopathic when the mechanism is not fully investigated.
Key principle: Gastroparesis is a motility disorder with identifiable mechanisms. Vagal dysfunction (diabetic, post-surgical, autonomic), hypothyroidism (reduces smooth muscle contractility), SIBO (bacterial metabolites impairing motility), medications (opioids, GLP-1 agonists, anticholinergics), and blood sugar instability (hyperglycemia directly slows gastric emptying) are all identifiable and treatable. "Idiopathic" gastroparesis often becomes explicable when these mechanisms are systematically evaluated.
Why Gastroparesis Matters
Clinical Impact
- Nutritional compromise: inability to eat adequate volumes produces weight loss, micronutrient deficiency, and caloric insufficiency
- Blood sugar management is impaired: unpredictable gastric emptying rates cause mismatch between insulin timing and glucose absorption in diabetic patients, producing dangerous glucose variability
- SIBO development: the migrating motor complex (MMC) that sweeps bacteria from the small intestine is impaired when gastric motility is slow, promoting SIBO development that further worsens motility
- Quality of life: chronic nausea, food avoidance, and unpredictable vomiting significantly impair daily function and social engagement
Why Standard Management Is Incomplete
- The mechanism is not systematically identified: once gastric emptying study confirms delayed emptying, treatment focuses on prokinetics without evaluating why the emptying is delayed
- Thyroid is not routinely evaluated: hypothyroidism directly reduces gastric smooth muscle contractility but is frequently missed as a gastroparesis contributor
- Blood sugar impact on motility is underappreciated: glucose levels above 200 mg/dL directly slow gastric emptying. Poor glycemic control produces gastroparesis that improves with blood sugar optimization
- SIBO and gastroparesis are bidirectional: each worsens the other, but SIBO testing is not part of standard gastroparesis evaluation
Common Symptoms
Digestive
- Nausea, often persistent
- Early satiety (full after small amounts)
- Bloating and upper abdominal distension
- Vomiting of undigested food hours after eating
Nutritional
- Unintentional weight loss
- Nutrient deficiencies
- Blood sugar instability
- Acid reflux from gastric stasis
Systemic
- Fatigue from malnutrition
- Dehydration
- Abdominal pain
- Food avoidance and anxiety around eating
Root Causes: A Functional Medicine Perspective
Gastroparesis has identifiable mechanisms at the vagal, autonomic, metabolic, and smooth muscle levels. Identifying which mechanism is dominant determines treatment.
Vagal Nerve Dysfunction
The vagus nerve provides the parasympathetic innervation that drives gastric contractions. Diabetic autonomic neuropathy is the most common cause of vagal gastroparesis, producing progressive damage to vagal nerve fibers through hyperglycemia-mediated oxidative stress and AGE formation. Post-surgical vagal damage (after fundoplication, bariatric surgery, or other upper abdominal procedures) produces acute-onset gastroparesis. Dysautonomia from autoimmune, post-infectious, or other causes produces vagal dysfunction that affects gastric motility alongside other autonomic functions.
Hypothyroidism
Hypothyroidism reduces the contractility of gastric smooth muscle directly and impairs the interstitial cells of Cajal pacemaker function. Subclinical hypothyroidism can produce gastric dysmotility before overt thyroid failure is diagnosed. Every gastroparesis evaluation should include a full thyroid panel (TSH, Free T3) because thyroid optimization alone can resolve the motility impairment in thyroid-driven cases.
SIBO and the Motility Cycle
SIBO and gastroparesis exist in a bidirectional cycle. Gastroparesis impairs the migrating motor complex that normally sweeps bacteria from the small intestine during fasting, allowing bacterial overgrowth. SIBO bacteria produce hydrogen sulfide and methane, which directly inhibit smooth muscle contractility and worsen gastric motility. Breaking this cycle requires treating the SIBO to remove the motility-inhibiting bacterial metabolites alongside prokinetic support to restore the MMC.
Medication-Induced Gastroparesis
Opioids slow gastric motility through mu-receptor mediated smooth muscle inhibition. GLP-1 receptor agonists (semaglutide, liraglutide, tirzepatide) delay gastric emptying as a therapeutic mechanism for diabetes and weight management, but can produce clinically significant gastroparesis. Anticholinergics, calcium channel blockers, and tricyclic antidepressants all reduce gastric contractility. Medication review is essential in every gastroparesis evaluation.
Conventional vs Functional Medicine Approach
| Domain | Conventional Medicine | Functional Medicine |
|---|---|---|
| Diagnosis | Gastric emptying study; upper endoscopy | Same plus mechanism identification: thyroid panel, SIBO breath test, autonomic evaluation, medication review, blood sugar assessment |
| Treatment | Metoclopramide, domperidone, dietary modification | Same prokinetics plus mechanism-specific treatment: thyroid optimization, SIBO treatment, blood sugar stabilization, vagal support, medication modification |
| Root Cause | Often labeled "idiopathic" | Systematic mechanism evaluation identifies treatable causes in a majority of "idiopathic" cases |
| Goal | Symptom management | Mechanism correction to restore gastric motility alongside symptom management |
Key Labs to Evaluate
HbA1cGlycemic control directly affects gastric emptying rate. Hyperglycemia above 200 mg/dL slows motility.
→TSHHypothyroidism reduces gastric smooth muscle contractility. Thyroid screening is essential in every gastroparesis evaluation.
→Free T3Active thyroid hormone determining tissue-level smooth muscle function. Low Free T3 impairs motility even with normal TSH.
→Fasting InsulinInsulin resistance drives the hyperglycemia that directly slows gastric emptying in diabetic and prediabetic patients.
→hs-CRPSystemic inflammation contributing to autonomic nerve damage and gastric dysmotility.
→How to Interpret These Labs Together
Gastroparesis with elevated HbA1c (above 7), elevated fasting insulin, and peripheral neuropathy identifies diabetic autonomic gastroparesis. Hyperglycemia is both causing the autonomic nerve damage and directly slowing gastric emptying through acute glucose-mediated smooth muscle inhibition. Aggressive blood sugar optimization is the highest-priority intervention: improving glycemic control improves gastric motility independently of prokinetic medication.
Gastroparesis with TSH of 4.2 and Free T3 at the bottom of the reference range identifies thyroid-driven dysmotility. Subclinical hypothyroidism is reducing smooth muscle contractility. Thyroid optimization alone can resolve the gastroparesis in these cases, avoiding the need for chronic prokinetic therapy.
Gastroparesis with positive SIBO breath test (elevated methane) identifies the SIBO-motility bidirectional cycle. Methane-producing archaea directly slow smooth muscle transit. SIBO treatment (rifaximin plus neomycin for methane-dominant) can produce significant motility improvement by removing the bacterial metabolites inhibiting gastric contractions.
Common Patterns Seen in Patients
- The "idiopathic" gastroparesis patient with undiagnosed hypothyroidism: gastric emptying study confirmed 22 percent retention at 4 hours. No mechanical obstruction on endoscopy. Labeled idiopathic. TSH 4.8, Free T3 at 2.3. Thyroid optimization with T4/T3 combination: gastric emptying normalized within 8 weeks. The gastroparesis was thyroid-driven. Nobody checked.
- The diabetic on metoclopramide for 2 years with worsening symptoms: HbA1c fluctuating between 7.5 and 9.0. Gastroparesis worsening despite prokinetics. SIBO breath test: methane-dominant SIBO. The uncontrolled glucose was both damaging the vagal nerve and directly slowing emptying, while the resultant SIBO was producing methane that further impaired motility. Triple intervention: blood sugar optimization, SIBO treatment, and prokinetic support. Gastroparesis symptoms improved by 65 percent.
- The patient on semaglutide who developed new gastroparesis: started GLP-1 agonist for weight management 4 months ago. Progressive nausea, early satiety, and bloating. GLP-1 agonists delay gastric emptying as their therapeutic mechanism, but can produce clinically significant gastroparesis in susceptible patients. Dose reduction and prokinetic support (ginger, artichoke extract) managed symptoms while maintaining the metabolic benefit of the GLP-1 at a lower dose.
Treatment and Optimization Strategy
Mechanism-Specific Gastroparesis Management
Prokinetic and Dietary
- Ginger (1 to 2g daily or ginger capsules): documented prokinetic effect through 5-HT3 antagonism and direct gastric smooth muscle stimulation. Evidence for accelerating gastric emptying in gastroparesis
- Artichoke extract and iberogast: prokinetic herbal combinations that stimulate gastric motility through serotonergic and cholinergic pathways
- Low-dose erythromycin (50 to 100mg before meals): motilin receptor agonist at sub-antibiotic doses. Most potent prokinetic available but limited by tachyphylaxis
- Dietary modification: smaller, more frequent meals (5 to 6 daily). Lower fat (fat slows emptying). Cooked over raw vegetables. Liquid/blended meals during flares. Avoid lying down after meals
Root-Cause Treatment
- Blood sugar optimization: reduce HbA1c below 7.0 to slow autonomic nerve damage and remove acute glucose-mediated motility inhibition
- Thyroid optimization: full thyroid panel assessment and treatment of hypothyroidism or subclinical hypothyroidism contributing to smooth muscle dysfunction
- SIBO treatment: rifaximin (hydrogen-dominant) or rifaximin plus neomycin (methane-dominant) to remove bacterial metabolites inhibiting motility
- Vagal nerve support: vagal tone exercises (cold water face immersion, slow diaphragmatic breathing, gargling), electrical vagal nerve stimulation when available
What Most Doctors Miss
- Thyroid is not evaluated: hypothyroidism directly impairs gastric smooth muscle contractility. A full thyroid panel should be standard in every gastroparesis workup. Thyroid optimization alone resolves gastroparesis in thyroid-driven cases.
- SIBO is not tested: the gastroparesis-SIBO bidirectional cycle means each worsens the other. SIBO breath testing should be performed in every gastroparesis patient, particularly those not responding to prokinetics alone.
- Blood sugar directly affects emptying rate: acute hyperglycemia above 200 mg/dL slows gastric emptying independently of autonomic neuropathy. Blood sugar optimization is a direct motility intervention, not just a diabetes management goal.
- Medications cause gastroparesis: opioids, GLP-1 agonists, anticholinergics, calcium channel blockers, and tricyclic antidepressants all impair gastric motility. Medication review should precede invasive evaluation.
When to Seek Medical Care
If you experience persistent nausea, early satiety, vomiting of undigested food, unintentional weight loss, or worsening blood sugar control alongside gastric symptoms, a comprehensive gastroparesis evaluation including gastric emptying study, thyroid panel, SIBO testing, and metabolic assessment is warranted.
Recommended Testing
Gastroparesis evaluation identifies the specific mechanism impairing gastric motility to guide treatment beyond prokinetics alone.
Diagnostic
- Gastric Emptying Study (4-hour)
- Upper Endoscopy (rule out obstruction)
- SIBO Breath Test (H2/CH4)
Mechanism Identification
- TSH, Free T3
- HbA1c, Fasting Insulin
- hs-CRP
- Vitamin B12 (autonomic neuropathy)
- Comprehensive Stool Analysis
Need metabolic and thyroid testing alongside gut assessment?
Explore All Testing Options →Frequently Asked Questions
What causes gastroparesis?
Impaired gastric motility from vagal nerve dysfunction (diabetic neuropathy, post-surgical damage, dysautonomia), hypothyroidism, medications (opioids, GLP-1 agonists), SIBO, and blood sugar instability. Up to 50 percent of cases are labeled "idiopathic" when the mechanism is not fully evaluated.
Can gastroparesis be cured?
Gastroparesis from reversible mechanisms (hypothyroidism, medications, SIBO, blood sugar instability) can be significantly improved or fully resolved. Diabetic autonomic gastroparesis is more difficult to reverse but progression can be halted and symptoms managed through blood sugar optimization and vagal support.
How is gastroparesis diagnosed?
Gastric emptying scintigraphy measures the rate of meal emptying. Retention above 10 percent at 4 hours confirms delayed emptying. Upper endoscopy rules out obstruction. The emptying study confirms the diagnosis; mechanism identification determines the treatment.
What diet is best for gastroparesis?
Smaller, more frequent meals. Lower fat (fat delays emptying). Cooked vegetables over raw. Liquid and blended meals during flares. Avoid carbonated beverages. The diet manages symptoms while the underlying mechanism is being treated.
Is gastroparesis related to SIBO?
Yes, bidirectionally. Gastroparesis impairs the MMC that clears bacteria from the small intestine, promoting SIBO. SIBO produces methane and hydrogen sulfide that further impair smooth muscle motility. Treating SIBO can improve gastric motility, and improving motility reduces SIBO recurrence.
How The Lamkin Clinic Approaches Gastroparesis
Clinical Perspective
When I see a gastroparesis patient, I want to know why the stomach is not emptying. Is the thyroid adequate? Is the blood sugar controlled? Is there SIBO producing methane that is directly inhibiting the smooth muscle? Is there a medication that is causing the problem? When I identify the specific mechanism and treat it, the motility improves. The patient who has been on metoclopramide for two years without improvement has an untreated mechanism. Finding that mechanism changes the outcome.
Brian Lamkin, DO | Founder, The Lamkin Clinic | Edmond, Oklahoma
At The Lamkin Clinic, gastroparesis evaluation includes gastric emptying confirmation alongside comprehensive mechanism identification: full thyroid panel (TSH, Free T3), metabolic assessment (HbA1c, fasting insulin), SIBO breath testing, medication review, and autonomic evaluation when indicated. Treatment combines prokinetic support with mechanism-specific intervention: thyroid optimization, blood sugar stabilization, SIBO treatment, and vagal nerve support to restore gastric motility at its source.
Related Conditions
SIBOBidirectional motility cycle: gastroparesis promotes SIBO, SIBO worsens gastroparesis
→DysautonomiaVagal nerve dysfunction as the primary autonomic mechanism of gastroparesis
→HypothyroidismThyroid-driven smooth muscle dysfunction producing gastric dysmotility
→Type 2 DiabetesDiabetic autonomic neuropathy as the most common identified cause of gastroparesis
→GERD and Acid RefluxGastric stasis producing reflux through intragastric pressure elevation
→Gut DysbiosisMicrobiome disruption from impaired motility and bacterial metabolite accumulation
→Related Symptoms
Chronic FatigueNutritional compromise and malabsorption from impaired gastric function producing energy decline
→Brain FogNutrient malabsorption and blood sugar instability impairing cognitive function
→Anxiety PhysiologyVagal dysfunction and gut-brain axis disruption producing anxiety alongside gastroparesis
→Depression BiologyChronic nausea, nutritional compromise, and quality of life impairment contributing to depressive symptoms
→Content authored and clinically reviewed by Brian Lamkin, DO, founder of The Lamkin Clinic in Edmond, Oklahoma. Brian Lamkin, DO has 25+ years of experience in functional and regenerative medicine. This page reflects current functional medicine practice standards and is updated as new clinical evidence becomes available.
Gastroparesis has identifiable mechanisms. Treating the mechanism restores motility.
The Lamkin Clinic evaluates gastroparesis through comprehensive mechanism identification including thyroid, SIBO, metabolic, and autonomic assessment to treat the cause of delayed emptying. Schedule a consultation.
Schedule a ConsultationMedical Disclaimer: This content is provided for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Lab interpretation should always be performed in clinical context by a qualified healthcare provider. Reference ranges and optimal targets may vary based on individual patient history, clinical presentation, and laboratory methodology. Schedule a consultation to discuss your specific results with Dr. Lamkin.